Cargando…
Early‐onset fetal growth restriction: A systematic review on mortality and morbidity
INTRODUCTION: Severe early‐onset fetal growth restriction is an obstetric condition with significant risks of perinatal mortality, major and minor neonatal morbidity, and long‐term health sequelae. The prognosis of a fetus is influenced by the extent of prematurity and fetal weight. Clinical care is...
Autores principales: | Pels, Anouk, Beune, Irene M., van Wassenaer‐Leemhuis, Aleid G., Limpens, Jacqueline, Ganzevoort, Wessel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004054/ https://www.ncbi.nlm.nih.gov/pubmed/31376293 http://dx.doi.org/10.1111/aogs.13702 |
Ejemplares similares
-
Detailed statistical analysis plan for the Dutch STRIDER (Sildenafil TheRapy In Dismal prognosis Early-onset fetal growth Restriction) randomised clinical trial on sildenafil versus placebo for pregnant women with severe early onset fetal growth restriction
por: Pels, Anouk, et al.
Publicado: (2019) -
Neonatal pulmonary hypertension after severe early-onset fetal growth restriction: post hoc reflections on the Dutch STRIDER study
por: Pels, Anouk, et al.
Publicado: (2022) -
Maternal Sildenafil vs Placebo in Pregnant Women With Severe Early-Onset Fetal Growth Restriction: A Randomized Clinical Trial
por: Pels, Anouk, et al.
Publicado: (2020) -
STRIDER: Sildenafil therapy in dismal prognosis early-onset intrauterine growth restriction – a protocol for a systematic review with individual participant data and aggregate data meta-analysis and trial sequential analysis
por: Ganzevoort, Wessel, et al.
Publicado: (2014) -
STRIDER (Sildenafil TheRapy in dismal prognosis early onset fetal growth restriction): an international consortium of randomised placebo-controlled trials
por: Pels, A., et al.
Publicado: (2017)